Marksans Pharma .
₹263.9
43
+₹4.9+1.89% Friday 10:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
108.76B
P/E Ratio
32.65
Dividend Yield
0.23%
Dividend
0.6
Upcoming
17
SEP
Dividend Ex
Increased
5
OCT
Dividend Payment
Increased
12
NOV
Earnings
17
SEP 25
Dividend Ex
Estimated
5
OCT 25
Dividend Payment
Estimated
17
SEP 26
Dividend Ex
Estimated
5
OCT 26
Dividend Payment
Estimated
Dividends
0.23%Dividend Yield
10Y Growth
19.62%
5Y Growth
64.38%
3Y Growth
33.89%
1Y Growth
20%
Earnings
12NovExpected
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MARKSANS.NSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Show more...
CEO
Mr. Mark B. Saldanha
Country
IN
ISIN
INE750C01026